Oxycodone and Valtoco drug interactions - a phase IV clinical study of FDA data
Summary:
The phase IV clinical study analyzes what interactions people have when they take Oxycodone and Valtoco. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.
What is Oxycodone?
Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,591 Oxycodone users. Check the latest studies of Oxycodone.
What is Valtoco?
Valtoco has active ingredients of diazepam. eHealthMe is studying from 400 Valtoco users. Check the latest studies of Valtoco.
5 people who take Oxycodone and Valtoco together, and have interactions are studied.
What are the common drug interactions of Oxycodone and Valtoco, by gender? *:
female:
n/a
male:
- Gamma-glutamyltransferase increased
- Protein total decreased
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Pyrexia (fever)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Vomiting
What are the common drug interactions of Oxycodone and Valtoco, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Gamma-glutamyltransferase increased
- Protein total decreased
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Pyrexia (fever)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Vomiting
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
n/a
* Approximation only. Some reports may have incomplete information.
Do you take Oxycodone and Valtoco?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Oxycodone and Valtoco:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Oxycodone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Valtoco:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Oxycodone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Valtoco and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on oxycodone hydrochloride and diazepam (the active ingredients of Oxycodone and Valtoco, respectively), and Oxycodone and Valtoco (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lidocaine and Cimzia - 3 seconds ago
- Drug interactions of Ziextenzo and Docetaxel - 18 seconds ago
- Could Pegasys cause Granulocyte Count Decreased? - 24 seconds ago
- Could Rapamune cause Chronic Obstructive Pulmonary Disease? - 26 seconds ago
- Hair Loss and Ocular Hyperaemia - 37 seconds ago
- Could Bactroban cause Respiratory Acidosis? - a minute ago
- Diuretic Therapy and Blood Pressure Systolic Increased - a minute ago
- Drug interactions of Anoro Ellipta and Letairis - a minute ago
- Drug interactions of Temazepam and Cialis - a minute ago
- Dymista vs. Symbicort, side effect and effectiveness comparison - a minute ago